Role of matrix metalloproteinase-8 in the modulation of systemic 5-fluorouracil pharmacokinetics by local irradiation

被引：0
|
作者：
Hsieh, C.
Liu, C.
Hsieh, Y.
Tai, H.
Wang, L.
Tsai, T.
Chen, Y.
机构：
[1] Far Eastern Mem Hosp, Taipei, Taiwan
[2] Mackay Mem Hosp, Taipei, Taiwan
[3] Natl Yang Ming Univ, Taipei 112, Taiwan
[4] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.466
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
466
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A novel mechanism for polymorphonuclear cell migration through collagen barriers: Role of matrix metalloproteinase-8
    Khatwa, U. A.
    Shapiro, S. D.
    Subramaniam, M.
    PEDIATRIC PULMONOLOGY, 2007, : 255 - 255
  • [42] Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases
    Rietveld, Pascale C. S.
    Guchelaar, Niels A. D.
    van Eerden, Ruben A. G.
    de Boer, Nadine L.
    de Bruijn, Peter
    Sassen, Sebastiaan D. T.
    Madsen, Eva V. E.
    Koch, Birgit C. P.
    Verhoef, Cornelis
    Burger, Jacobus W. A.
    Mathijssen, Ron H. J.
    Koolen, Stijn L. W.
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 176
  • [43] Regional pharmacokinetics of 5-fluorouracil in dogs: Role of the liver, gastrointestinal tract, and lungs
    Kuan, HY
    Smith, DE
    Ensminger, WD
    Knol, JA
    DeRemer, SJ
    Yang, ZM
    Stetson, PL
    CANCER RESEARCH, 1998, 58 (08) : 1688 - 1694
  • [44] Reduction in matrix metalloproteinase production by tendon and synovial fibroblasts after a single exposure to 5-fluorouracil
    Ragoowansi, R
    Khan, U
    Brown, RA
    McGrouther, DA
    BRITISH JOURNAL OF PLASTIC SURGERY, 2001, 54 (04): : 283 - 287
  • [45] In vivo modulation of 5-fluorouracil (5FU) pharmacokinetics by eniluracil, and inactivator of dihydropyrimidine dehydrogenase (DPD)
    Saleem, A
    Abaogye, EO
    Yap, J
    Osman, S
    Purnell, C
    O'Callaghan, M
    Lucas, VS
    Jones, T
    Price, PM
    BRITISH JOURNAL OF CANCER, 1999, 80 : 94 - 94
  • [46] Extracellular Matrix Modulation Therapy of Pancreatic Cancer by 4-methylumbelliferone and 5-fluorouracil
    Yoshida, E.
    Kudo, D.
    Nagase, H.
    Suto, A.
    Wakiya, T.
    Ishido, K.
    Toyoki, Y.
    Hakamada, K.
    PANCREAS, 2015, 44 (08) : 1427 - 1427
  • [47] Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy
    Sivula, M.
    Hastbacka, J.
    Kuitunen, A.
    Lassila, R.
    Tervahartiala, T.
    Sorsa, T.
    Pettila, V.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2015, 59 (02) : 176 - 184
  • [48] Modulation of the pharmacokinetics of 5'-deoxy-5-fluorouridine and 5-fluorouracil in rats by oral co-administration of acyclothymidine
    Hamada, A
    Fukushima, S
    Saneyoshi, M
    Shimizu, S
    Kawaguchi, T
    Nakano, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1996, 19 (05) : 729 - 732
  • [49] Evaluation of Local Pharmacokinetics of 5-Fluorouracil in Dog Pancreas by EUS-Guided In Vivo Microdialysis
    Kitano, M.
    Sakamoto, H.
    Komaki, T.
    Das, K.
    Imai, H.
    Kamata, K.
    Kudo, M.
    PANCREAS, 2009, 38 (08) : 1017 - 1018
  • [50] Role of Cilostazol in Rats with Diabetic Lower Limb Ischemia and Its Influences on Changes in Matrix Metallopeptidase-9 and Matrix Metalloproteinase-8
    Tang, Yao
    Huang, Jian
    Shen, Liming
    Liu, Zhanao
    Zhou, Dayong
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (03) : 402 - 407
12345